JP4469280B2 - ムスカリン性アゴニスト - Google Patents
ムスカリン性アゴニスト Download PDFInfo
- Publication number
- JP4469280B2 JP4469280B2 JP2004530846A JP2004530846A JP4469280B2 JP 4469280 B2 JP4469280 B2 JP 4469280B2 JP 2004530846 A JP2004530846 A JP 2004530846A JP 2004530846 A JP2004530846 A JP 2004530846A JP 4469280 B2 JP4469280 B2 JP 4469280B2
- Authority
- JP
- Japan
- Prior art keywords
- fluorobenzyl
- carboxylic acid
- hydroxyindan
- methylamino
- ethylideneamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 C*C(C)C*C1=CCC(C)(C[C@@]([C@@]2NC(c(cc3)ccc3-c3ccccc3)=O)O)C2=C1 Chemical compound C*C(C)C*C1=CCC(C)(C[C@@]([C@@]2NC(c(cc3)ccc3-c3ccccc3)=O)O)C2=C1 0.000 description 1
- JTTOKZIZNXDTFA-UHFFFAOYSA-N CNCC(C=C1)=CCC1F Chemical compound CNCC(C=C1)=CCC1F JTTOKZIZNXDTFA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 | |
| PCT/US2003/023260 WO2004018411A1 (en) | 2002-08-22 | 2003-08-12 | Muscarinic agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005536549A JP2005536549A (ja) | 2005-12-02 |
| JP2005536549A5 JP2005536549A5 (https=) | 2006-09-28 |
| JP4469280B2 true JP4469280B2 (ja) | 2010-05-26 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004530846A Expired - Fee Related JP4469280B2 (ja) | 2002-08-22 | 2003-08-12 | ムスカリン性アゴニスト |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (https=) |
| EP (1) | EP1534667B1 (https=) |
| JP (1) | JP4469280B2 (https=) |
| CN (1) | CN100554247C (https=) |
| AR (1) | AR040889A1 (https=) |
| AT (1) | ATE491683T1 (https=) |
| AU (1) | AU2003256791B2 (https=) |
| BR (1) | BR0313161A (https=) |
| CA (1) | CA2493958C (https=) |
| CY (1) | CY1111115T1 (https=) |
| DE (1) | DE60335380D1 (https=) |
| DK (1) | DK1534667T3 (https=) |
| ES (1) | ES2355213T3 (https=) |
| MX (1) | MXPA05002080A (https=) |
| PE (1) | PE20040894A1 (https=) |
| PT (1) | PT1534667E (https=) |
| SI (1) | SI1534667T1 (https=) |
| TW (1) | TW200410922A (https=) |
| WO (1) | WO2004018411A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2013523679A (ja) | 2010-03-29 | 2013-06-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 殺菌性イミノ誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA76492C2 (en) * | 2001-09-21 | 2006-08-15 | Lilly Co Eli | Muscarinic agonists, a pharmaceutical composition on their basis |
-
2003
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en not_active Ceased
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2493958A1 (en) | 2004-03-04 |
| WO2004018411A1 (en) | 2004-03-04 |
| CN1675173A (zh) | 2005-09-28 |
| BR0313161A (pt) | 2005-06-14 |
| ES2355213T3 (es) | 2011-03-23 |
| CY1111115T1 (el) | 2015-06-11 |
| JP2005536549A (ja) | 2005-12-02 |
| MXPA05002080A (es) | 2005-08-18 |
| PE20040894A1 (es) | 2004-11-25 |
| CN100554247C (zh) | 2009-10-28 |
| AR040889A1 (es) | 2005-04-20 |
| DK1534667T3 (da) | 2011-02-14 |
| DE60335380D1 (de) | 2011-01-27 |
| US7160922B2 (en) | 2007-01-09 |
| TW200410922A (en) | 2004-07-01 |
| EP1534667B1 (en) | 2010-12-15 |
| EP1534667A1 (en) | 2005-06-01 |
| AU2003256791A1 (en) | 2004-03-11 |
| ATE491683T1 (de) | 2011-01-15 |
| AU2003256791B2 (en) | 2008-12-11 |
| US20060122280A1 (en) | 2006-06-08 |
| CA2493958C (en) | 2010-11-09 |
| SI1534667T1 (sl) | 2011-02-28 |
| PT1534667E (pt) | 2011-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1051394B1 (en) | Potassium channel inhibitors | |
| JP4196829B2 (ja) | ５，８，１４−トリアザテトラシクロ［１０．３．１．０２，１１．０４，９］−ヘキサデカ−２（１１），３，５，７，９−ペンタエンのコハク酸塩およびその医薬組成物 | |
| JP2007520440A (ja) | ムスカリン性受容体アゴニストとしてのインダン誘導体 | |
| EP1436249B1 (en) | Muscarinic agonists | |
| JP4116431B2 (ja) | ラクタム化合物 | |
| JP2004521084A5 (https=) | ||
| JP2015507022A (ja) | ３−（４−ニトロ−１−オキソイソインドリン−２−イル）ピペリジン−２，６−ジオンの固体形態 | |
| JP4469280B2 (ja) | ムスカリン性アゴニスト | |
| US6825193B2 (en) | Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof | |
| JP2005538031A (ja) | ラクタム化合物 | |
| RS49504A (sr) | Kristalni oblik derivata ribofuranoziluroamida: agonist humanog adenozin a2a receptora | |
| CN114853762A (zh) | 一种咪唑并三嗪类化合物的固体形式及其制备方法和用途 | |
| TWI886914B (zh) | -3-酮衍生物枸櫞酸鹽的晶型、製備方法及其用途 | |
| CN113861182B (zh) | 嘧啶噻唑甲酰胺化合物的磷酸盐及其晶型 | |
| US20250304635A1 (en) | Birinapant polymorph h | |
| EP4174065A1 (en) | Salt of 2-(substituted pyrimidinyl)thiazolecarboxamide compound, and composition and use thereof | |
| WO2025162114A1 (zh) | 一种杂环化合物及其用途 | |
| EP3939578A1 (en) | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease | |
| EP3822264A1 (en) | Crystal forms of oxypyridine amide derivative and preparation method therefor | |
| JP2025527600A (ja) | グルコシルセラミド合成酵素阻害薬の結晶形及びその使用 | |
| CN115636757A (zh) | 一种帕莫酸托特罗定盐及其合成方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060810 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060810 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080911 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091111 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A132 Effective date: 20091117 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091216 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20091216 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100202 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100226 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130305 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130305 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140305 Year of fee payment: 4 |
|
| LAPS | Cancellation because of no payment of annual fees |